Cara Therapeutics Funding: $56M Raised, Series D (2010)
Cara Therapeutics is based in Stamford. It has raised $56M in total funding. Latest round: Series D.
Cara Therapeutics funding overview
Cara Therapeutics is based in Stamford. Cara Therapeutics has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in July 2010. The round record for Cara Therapeutics runs through 2010; nothing later has been disclosed. Investors on record include Martin Vogelbaum, Connecticut Innovations, Digitalis Ventures, Alta Partners, Ascent Biomedical Ventures, Devon Park Bioventures and 4 others. 10 distinct backers are named across the disclosed rounds.
Cara Therapeutics at a glance
Total raised
$56M
Latest round
Series D
Latest round date
July 2010
Headquarters
Stamford
Notable investors
Martin Vogelbaum, Connecticut Innovations, Digitalis Ventures, Alta Partners, Ascent Biomedical Ventures, Devon Park Bioventures, Healthcare Private Equity, Mitsubishi Corporation
Frequently asked about Cara Therapeutics funding
How much has Cara Therapeutics raised?
Cara Therapeutics has raised $56M in total disclosed funding across the rounds on record.
Who has invested in Cara Therapeutics?
Martin Vogelbaum, Connecticut Innovations, Digitalis Ventures, Alta Partners, Ascent Biomedical Ventures, Devon Park Bioventures are named among the investors backing Cara Therapeutics.
What was the latest Cara Therapeutics funding round?
The most recent disclosed round is a Series D, announced in July 2010.
Where is Cara Therapeutics based?
Cara Therapeutics is based in Stamford.
When did Cara Therapeutics last raise?
The last disclosed Cara Therapeutics round closed in July 2010 at Series D.
Cara Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Stamford below to benchmark round size and investor mix.
